Login
Home / ACUR : OTC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis News Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Acura Pharmaceuticals, Inc.

$0 -$0.00 (-80.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0.01
Market Cap
6.6K
AVG Volume
712
Trailing/Forward PE
-0.01/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
0500K1M1.5M19 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q4
Net Income (USD)
-750K-500K-250K0250K500K19 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q4
Operating Income (USD)
-750K-500K-250K0250K500K19 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q4
EBITDA (USD)
-750K-500K-250K0250K500K19 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q4
Cash Flows (USD)
-1M-500K0500K1M19 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q4
EPS (USD)
-0.03-0.02-0.0100.0119 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q4
Expenses (USD)
-500K0500K1M1.5M2MR&DSG&ACapex19 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q4
Cash & Debt (USD)
02M4M6M8MCashLong Term DebtShort Term Debt19 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q4
Debt ratios
-40-30-20-1001019 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q4
Margins
-100%-50%0%50%100%19 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q4
Return on Capital
-200%-100%0%100%19 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q4
Shares Outstanding
020M40M60M80M19 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q4
Book Value Per Share (USD)
-0.2-0.15-0.1-0.05-00.0519 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q4
Total Assets (USD)
01M2M3M19 Q319 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q4
Employee Count
0510152012201320142015201620172018201920202021
PE Ratio
050100150med 105.51May 12Jun 12Jul 12Aug 20Sep 20Oct 20Nov 20
Free Cash Flow Yield
-10000%-7500%-5000%-2500%0%med -1962.86%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
00.250.50.751med 0.02Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
5101520med 16.76May 12Jun 12Jul 12Aug 20Sep 20Oct 20Nov 20
Price/Operating Cashflow
020406080100med 10.49May 12Jun 12Jul 12Jul 20Sep 20Oct 20Nov 20
Price to Book
02.557.510med 0.21Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Acura Pharmaceuticals, Inc.
ACUR
Stockpicker

Video analysis: ACUR

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ACUR

Acura Pharmaceuticals (OTCMKTS:ACUR) Shares Cross Above Two Hundred Day Moving Average – Should You Sell?

defenseworld.net · 22 Aug 2026

Acura Pharmaceuticals (OTCMKTS:ACUR) Shares Cross Above Two Hundred Day Moving Average – Should You Sell?

Shares of Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR - Get Free Report) crossed above its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $0.00 and traded as high as $0.0001. Acura Pharmaceuticals shares last traded at $0.00, with a volume of 0 shares changing hands.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.